AAAAAA
Results:
1-10
|
Results: 10
Authors:
Aschele, C
Sartor, L
Lonardi, S
Friso, M
Monfardini, S
Citation: C. Aschele et al., Oxaliplatin in rectal cancer. Clinical aspects: The medical oncologist point of view, TUMORI, 87(4), 2001, pp. S29-S30
Authors:
Friso, ML
Aschele, C
Pucciarelli, S
Fabris, G
Martella, B
Munegato, M
Ranzato, R
Neri, D
Fasano, C
Lora, O
Loreggian, L
Toppan, P
Muzzio, PC
Sotti, G
Citation: Ml. Friso et al., Feasibility of preoperative radiotherapy with weekly oxaliplatin (OXA), 5-fluorouracil (5-FU) continuous infusion in the treatment of locally advanced rectal cancer: Phase I study, TUMORI, 87(4), 2001, pp. S109-S109
Authors:
Sobrero, A
Guglielmi, A
Cirillo, M
Recaldin, E
Frassineti, GL
Aschele, C
Ravaioli, A
Testore, P
Caroti, C
Gallo, L
Pessi, MA
Cortesi, E
Turci, D
Grossi, F
Labianca, R
Citation: A. Sobrero et al., 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highlyeffective, low cost chemotherapy for advanced colorectal cancer, BR J CANC, 84(8), 2001, pp. 1023-1028
Authors:
Aschele, C
Debernardis, D
Tunesi, G
Maley, F
Sobrero, A
Citation: C. Aschele et al., Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil, CLIN CANC R, 6(12), 2000, pp. 4797-4802
Authors:
Cascinu, S
Catalano, V
Aschele, C
Barni, S
Debernardis, D
Gallo, L
Bandelloni, R
Staccioli, MP
Baldelli, AM
Brenna, A
Valenti, A
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Immunohistochemical determination of p53 protein does not predict clinicalresponse in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination, ANN ONCOL, 11(8), 2000, pp. 1053-1056
Authors:
Sobrero, A
Zaniboni, A
Frassineti, GL
Aschele, C
Guglielmi, A
Giuliani, R
Ravaioli, A
Lanfranco, C
Caroti, C
Arnoldi, E
Barni, S
Gallo, L
Pessi, MA
Turci, D
Cortesi, E
Grossi, F
Frontini, L
Piazza, E
Bruzzi, P
Labianca, R
Citation: A. Sobrero et al., Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study, ANN ONCOL, 11(11), 2000, pp. 1413-1420
Authors:
Sobrero, A
Guglielmi, A
Grossi, F
Puglisi, F
Aschele, C
Citation: A. Sobrero et al., Mechanism of action of fluoropyrimidines: Relevance to the new developments in colorectal cancer chemotherapy, SEMIN ONCOL, 27(5), 2000, pp. 72-77
Authors:
Cascinu, S
Aschele, C
Barni, S
Debernardis, D
Baldo, C
Tunesi, G
Catalano, V
Staccioli, MP
Brenna, A
Muretto, P
Catalano, G
Citation: S. Cascinu et al., Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil, CLIN CANC R, 5(8), 1999, pp. 1996-1999
Authors:
Aschele, C
Debernardis, D
Casazza, S
Antonelli, G
Tunesi, G
Baldo, C
Lionetto, R
Maley, F
Sobrero, A
Citation: C. Aschele et al., Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy, J CL ONCOL, 17(6), 1999, pp. 1760-1770
Authors:
Aschele, C
Casaretti, R
Cascinu, S
Cavaliere, R
Colucci, G
Comandone, A
Comella, G
Cortesi, E
Cosimelli, M
De Conno, F
Di Costanzo, F
Falcone, A
Fosser, V
Frassineti, L
Gardani, G
Goffredo, F
Ruggieri, FG
Labianca, R
Maiello, E
Nitti, D
Pozzo, C
Pugliese, P
Rinieri, MT
Roila, F
Severini, A
Sobrero, A
Spinelli, P
Tamburini, M
Torri, V
Terzoli, E
Zaniboni, A
Citation: C. Aschele et al., Treatment of patients with colorectal cancer - Introduction, TUMORI, 84(4), 1998, pp. S1
Risultati:
1-10
|